Market closedNon-fractional
AstraZeneca/AZN
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About AstraZeneca
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Ticker
AZN
Sector
Healthcare
Trading on
LSE
Industry
Pharmaceuticals
Headquarters
Cambridge, United Kingdom
Employees
89,900
Website
www.astrazeneca.com
AstraZeneca Metrics
BasicAdvanced
£187B
Market cap
40.83
P/E ratio
£2.95
EPS
-
Beta
£1.53
Dividend rate
1.27%
Dividend yield
Price and volume
Market cap
£187B
Dividend rate
£1.53
Financial strength
Current ratio
0.889
Quick ratio
0.69
Long term debt to equity
71.304
Total debt to equity
84.966
Dividend payout ratio (TTM)
69.29%
Interest coverage (TTM)
8.72%
Management effectiveness
Return on assets (TTM)
6.94%
Return on equity (TTM)
16.74%
Valuation
Price to earnings (TTM)
40.831
Price to revenue (TTM)
4.891
Price to book
4.73
Price to tangible book (TTM)
-8.91
Price to free cash flow (TTM)
34.109
Dividend yield (TTM)
1.27%
Growth
Revenue change (TTM)
10.45%
Earnings per share change (TTM)
-4.06%
3-year revenue growth (CAGR)
18.50%
3-year earnings per share growth (CAGR)
9.80%
3-year dividend per share growth (CAGR)
-11.06%
What the Analysts think about AstraZeneca
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for AstraZeneca stock.
AstraZeneca Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AstraZeneca Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
AstraZeneca News
AllArticlesVideos
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG
Market closedNon-fractional
Upcoming events
Aug
8
AstraZeneca
Dividend·Ex-dividend
Sept
9
AstraZeneca
Dividend·Payment
£1.00
Per share
FAQs
What’s the current market cap for AstraZeneca stock?
AstraZeneca (AZN) has a market cap of £187B as of July 26, 2024.
What is the P/E ratio for AstraZeneca stock?
The price to earnings (P/E) ratio for AstraZeneca (AZN) stock is 40.83 as of July 26, 2024.
Does AstraZeneca stock pay dividends?
Yes, the AstraZeneca (AZN) stock pays dividends to shareholders. As of July 26, 2024, the dividend rate is £1.53124 and the yield is 1.27%. AstraZeneca has a payout ratio of 69.29% on a trailing twelve-month basis.
When is the next AstraZeneca dividend payment date?
The next AstraZeneca (AZN) dividend payment is scheduled for September 09, 2024.
What is the beta indicator for AstraZeneca?
AstraZeneca (AZN) does not currently have a Beta indicator.
Buy or sell AstraZeneca stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.